Filing Details

Accession Number:
0001562180-19-001422
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-26 17:12:24
Reporting Period:
2019-02-22
Accepted Time:
2019-02-26 17:12:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656328 Sienna Biopharmaceuticals Inc. SNNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1573074 Frederick Iii Beddingfield C/O Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road, Suite 140
Westlake Village CA 91362
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-22 40,000 $2.50 831,662 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 112,614 Indirect See Footnote
Footnotes
  1. The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's public offering at the offering price of $2.50 per share.
  2. The shares are directly held by the Beddingfield Family Trust.